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Abstract
Background: Structured care is proposed as a lever fo r improving care fo r patients w ith chronic 
conditions. The purpose o f this study was to  explore the associations o f structured care 
characteristics, derived from the Chronic Care Model, w ith health-related quality o f life (HRQOL) 
and optimal clinical management in chronic heart failure (CHF) patients in primary care, as well as 
the association between optimal management and HRQOL.
Methods: Cross-sectional observational study using multi-level random-coefficient analyses o f a 
representative sample o f 357 patients diagnosed w ith CHF from 42 primary care practices in the 
Netherlands. W e  combined individual medical record data w ith patient and physician 
questionnaires.
Results: There was large variation in the levels and presence o f structured care elements. A  91% 
o f physicians indicated that next appointments fo r CHF patients were made immediately after visits, 
while 1 1% indicated that reminders on CHF management were periodically received in the ir 
practice. Few associations were found between the organizational characteristics and optimal 
treatm ent o r HRQOL. Optimal pharmacological treatm ent related to  better quality o f life (P = - 
11.5, P < .0001). Also, more lifestyle advice was given in practices w ith an appointment system 
allowing contact w ith more than one professional during the encounter (P = 1.0, P = .04).
Conclusion: HRQ OL and treatm ent quality in CHF patients were not consistently associated w ith 
characteristics o f structured care in primary care practices.
Background
In high-income countries, the prevalence of chronic heart 
failure (CHF) is estimated to be 1-2% [1], and expecta­
tions are that this figure will be rising as survival of acute 
heart disease is increasing [1,2]. CHF has high hospital 
admission rates [3], and severely compromises health-
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related quality of life (HRQOL) [4]. Many CHF patients 
are managed in primary care, but research on organiza­
tion of primary care for CHF is limited. Guidelines on the 
management of CHF recommend pharmacological treat­
m ent to deal with heart failure symptoms and to reduce 
morbidity and mortality in nearly all patients: in particu­
lar ACE inhibitors (ACEI) or angiotensin-II receptor 
blockers (ARB) and P-blockers [5-7]. In addition, clinical 
guidelines [5-7] incorporate principles of structured 
chronic care such as patient counselling on self manage­
m ent to promote continuity of care. Patients are to be 
monitored regularly with (daily) body weight measure­
ments and are to receive lifestyle advice, such as reducing 
salt intake, limiting fluid intake, exercise, and resting peri­
ods.
The goal of guidelines is to improve the survival and qual­
ity of life of patients in daily life. Consistently, studies 
show suboptimal adherence to guidelines in management 
of heart failure, especially in primary care [8,9]. There is a 
growing belief that structural support at the organiza­
tional level is needed to enhance guideline implementa­
tion [10-12]. Structured chronic care is considered 
increasingly im portant to optimize clinical management 
of patients with chronic diseases [13,14]. Studies in diabe­
tes indicated that the level of the organizations' use of 
physician reminders [15], performance feedback [15,16], 
involvement of patients in defining treatment goals [16], 
patient education [17] and structured care management 
[15,16] is positively associated with better outcomes. 
There is evidence that improvements in health care deliv­
ery improve health outcomes as HRQOL and limit the 
need for hospitalizations as well as improve prescribing 
practices for patients with chronic heart failure [13,18­
22]. However, little is known about the relationship 
between the presence of these elements and indicators of 
quality of CHF care in primary care. Such insight is impor­
tant, since it may guide the design of future practice m od­
els for heart failure care to improve HRQOL in CHF 
patients.
In this study we explored the extent to which structured 
chronic care features, derived from the Chronic Care 
Model, are associated with HRQOL and optimal manage­
m ent in heart failure in primary care. We also studied the 
associations between clinical management and HRQOL.
Methods
Design and population
In the period 2005-2006, we performed an observational 
study including 72 GPs in 42 primary care practices in the 
Netherlands. The sample of practices accounted for 
urbanization rate and types of practice.
GPs received tailored written instructions how to extract a 
list of patients with CHF from their electronic medical 
record system (EMR). Subsequently, they were asked to 
assess whether the patients on the EMR list met the diag­
nostic criteria of the ICPC code K77 (heart failure). This 
was to limit the num ber of false-positive CHF diagnoses. 
All patients with a diagnosis of CHF according to the GP 
were eligible to be included. Reasons for exclusion were: 
terminal illness, Dutch language problems, mental 
impairment, or other practical reasons to not include the 
patient in this study. GPs sent their patients (893 in total) 
an invitational letter, asking for informed consent. Con­
sent was received from 511 patients. Ethical approval for 
this study was waived by the ethics committee Arnhem­
Nijmegen.
O utcom e m easures
HRQOL was measured through the Dutch version of the 
Minnesota Living with Heart Failure Questionnaire [23]. 
This disease-specific 21-item questionnaire has been 
widely used in clinical trials and shows documented reli­
ability, validity and sensitivity [23,24]. The instrument 
uses a six-point Likert scale, indicating to what extent CHF 
influences patient's life during the m onth previous to 
measurement (ranging from 0: no influence, to 5: HF 
influenced the patient's life to a very high extent). If an 
item was no t applicable to a patient, a '0' was recorded. 
Per patient, a total score was computed by summing the
21 items (summary range 0-105), with the lower scores 
reflecting better HRQOL. We imputed missing values (per 
person mean substitution). The scale ratings were 
excluded if less than 16 answers per patient were entered. 
Internal consistency reliability, using Chronbach's alpha 
was 0.94.
Our second outcome measure was the sum score on eight 
measures of lifestyle advice to CHF patients [5-7] (see 
Table 1; measurements at individual patient level). Here, 
Chronbach's alpha was 0.86. A patient receives a score 
between 0 and 8, as each indicator received either a score 
of '1' or '0'. All patient items were assessed through 
printed questionnaires that were sent to 461 patients 
around the date of medical record data collection. All 
patients that handed in a written informed consent 
received a questionnaire, unless the patient had died in 
the meantime, or there were reasons for exclusion as 
judged by the GP. After three weeks reminders were sent. 
Questionnaires were received from 385 patients (83.5% 
response rate).
Our third outcome measure was a dichotomous variable 
that indicated whether a patient had received optimal 
pharmacological treatment. This variable was based on a 
global adherence index (GAI) for key-pharmacological 
recommendations [5-7]. For each patient, this index indi-
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cated the proportion of evidence-based recommendations 
followed by the GP out of the total num ber of recommen­
dations that applied for that particular patient [25]. The 
GAI included the prescription of ACEI (or ARB) for all 
patients, P-blockers of proven efficacy in CHF (bisoprolol, 
carvedilol or metoprolol) [5-7] in patients with previous 
MI or NYHA class > II) and spironolactone (in patients 
NYHA class > III). The measure was scored '1' for each 
individual patient if the patient received all indicated 
drugs. Information on pharmacological treatment was 
obtained from scrutinizing the patients' records by trained 
research staff. Due to limited resources, collection of m ed­
ical record data was limited to a random sample of a max­
imum of 15 patients per practice.
Independent m easures
Organizational characteristics were measured using writ­
ten validated questionnaires for physicians sent to all 72 
GPs in our sample. They worked in 49 physician groups in 
42 separate practices (response rate 88%). We distin­
guished between general organizational characteristics 
such as location of organization, list size, and age and 
num ber of years of experience of physicians and aspects of 
structured chronic care including items addressing four of 
the domains of the Chronic Care Model [13,14,26]: self­
management support, design of the care delivery system, 
decision support, and supportive clinical information sys­
C ha rac te ris tic (% yes)
Regular clinical meetings on CHF patients 18.8
Special hours for patients with heart disease 10.4
Agreements with cardiologist on sharing of information and organization of care 24.5
Decision support
• Info materials present fo r patients regarding guideline adherence 58.5
• Presence of HF protocol in practice 88.6
Delivery system design
• Next appointment made immediately after visit 91.1
• Continuity of care for CHF patients is a high priority 88.9
• Frequency and content of visit are tailored to  individual patients 100.0
• Clear tasks and responsibilities practice members 31.8
• Someone who assures that tasks and responsibilities are clearly defined 34.9
• Appointment system facilitates the patient seeing multiple practice employees in a single visit 13.8 #
Self-management support
• Assessment and documentation of self-management needs and activities is part o f the treatment 84.4
• Patient involvement in treatment plans 86.7
• Someone responsible for self-management in patients with HF 16.3
Clinical information systems
• Reminders build in EMR 25.0
• Reminders are periodically received 11.1
• Information related to  the needs of HF patients is provided to  practice members 16.7
Sum score structured care characteristics (0 -17 ; mean, SD) 8.3 (2.7)
#  significant association with lifestyle advice: p = 1.0; 95% CI (0.0, 2.0); p = 0.04
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Tab le  1: characteristics o f th e  patients (N  = 357)
Age (mean years, SD) 75.7 (10.2)
Sex (% male) 52.9
NYHA class (% I & II) 73.1
Optimal pharmacological treatment (% yes) 33.1
ACE/ARB (%) 58.3
P-blockers 46.9
Spironolactone 31.0
Lifestyle advice (0 -  8) (mean, SD) 4.4 (2.7)
Heart signs and symptoms (% yes) 58.3
Type of heart disorder 52.8
Medication intake 54.2
Reduced salt and limited fluid intake 37.5
Physical activity 41.6
Flu prevention 91.1
Weighing regularly 54.7
Coping behaviour 42.8
Quality of Life (0 -  105, less is better) (mean, SD) 30.5 (24.8)
Men 26.3 (l.9)
Women 35.5 (2.4)
NYHA class I 15.5 (l.5)
NYHA class II 36.6 (2.4)
NYHA class III 51.5 (2.7)
NYHA class IV 57.4 (l 1.3)
< 75 27.0 (2.3)
> 75 33.5 (2.0)
Tab le  2: s tructured  care characteristics in 49 physician groups
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tem (Table 2). Self-management support emphasizes 
patients' responsibility in  managing their health through 
such strategies as resolving problems, and devising action 
plans. An active delivery system design facilitates planned 
patient visits and includes the existence of practice teams 
with a division of tasks. Decision support enhances adher­
ence to evidence-based guidelines, incorporated in  daily 
practice decision making through system reminders and/ 
or prompts. They are reinforced through provider training 
or other decision support mechanisms. Clinical informa­
tion systems provide access to patient data and can be 
used to plan individual patient's care, identify relevant 
subpopulations for care, and m onitor the performance of 
health care providers. Items are based on the elements as 
specified in the Assessment of Chronic Illness Care instru­
m ent [27], which was translated from English to Dutch by 
a bilingual researcher, followed by back-translation from 
Dutch to English by a second bilingual researcher. Dis­
crepancies between the original questionnaire items and 
the back-translation were identified and solved with a 
third bilingual researcher. All researchers were familiar 
with the theoretical constructs. Items were either dichoto- 
mous (e.g. "Is there someone responsible for self-manage­
m ent in patients with CHF in your practice?"), or based on 
a five-point Likert scale ranging from 'always' to 'never' 
(e.g. "Are CHF patients involved in making treatment 
plans?"), which were rescaled to a binary variable ('never' 
and 'rarely' = 0; 'regularly', 'usually', and 'always' = 1). 
Items were excluded if they were missing in >10% of cases. 
The remaining items are listed in  Table 2. Since the inter­
nal consistency as measured by Chronbach's alpha of the 
scales varied widely (ranging from 0.27 to 0.75), we used 
the single items in  the analyses. In addition, we calculated 
a sum score of the structured care characteristics, ranging 
from 0 to 17.
Data-analysis
Patients without a date of diagnosis or medical record 
data were excluded from the study (N = 121). Thirty three 
(6.4%) patients had died between inclusion and medical 
record abstraction. In total, 154 patients were excluded, 
leaving 357 patients for this study. Excluded patients did 
not differ significantly from included patients with respect 
to age, sex, and NYHA class.
We analyzed data on the patient level. Patient data was 
merged with physician data. In case several GPs were see­
ing the same patients their data were aggregated before 
merging. In case of continuous variables, means were cal­
culated across physicians within the same physician group 
(one or more physicians seeing the same panel of 
patients). If disagreements existed between physicians 
regarding the dichotomous variables, such as presence of 
a HF protocol in  practice, they were contacted for clarifi­
cation. In a few remaining cases, scores higher then '0',
were scored '1'. The aggregated GP data were then merged 
with the patient data set, in  such a way that each patient 
treated by more than one physician had the same value on 
these particular GP variables. Descriptive analyses of 
patients' characteristics were performed (Table 1). For the 
description of physician characteristics, means and pro­
portions were calculated across physician practice groups.
Bivariate associations were explored between the struc­
tured care characteristics on the one hand, and manage­
m ent and HRQOL on the other, using random-coefficient 
regression analyses for the HRQOL and the lifestyle advice 
outcomes, and random-coefficient logistic regression 
analyses for the dichotomous outcome (optimal pharma­
cological treatment). If items showed hardly any variation 
between physicians (<10%), they were excluded from the 
bivariate analyses. Random-coefficient analyses were per­
formed to correct for the clustering effect of the design, 
patients (level 1) were clustered within physician groups 
(level 2). For statistically significant associations (P < .05), 
we repeated the analyses using patient age, gender and -  
in  case of the lifestyle management and HRQOL out­
comes -  NYHA class as possible confounders. In addition, 
we explored whether optimal pharmacological manage­
m ent and lifestyle advice were related to HRQOL in ran­
dom-coefficient regression analyses using the same 
confounders. All analyses were performed using SPSS 14, 
except for the multi-level logistic regression analyses that 
were performed using the Glimmix procedure in  SAS for 
Windows V8.2.
Results
Patien t characteristics
Table 1 shows the characteristics of the patients. 73% of 
patients were classified as NYHA I or II. The mean age of 
the patients was 75.7 years (SD 10.2), and 52.9% was 
male. Around 33% of patients received optimal pharma­
cological treatment, the average num ber of lifestyle advice 
patients received was 4.4 (SD 2.7). The mean HRQOL 
score was 30.5. Hence, on average, patients scored 1.45 on 
the Likert scales (ranging from 0: no influence, to 5: CHF 
influenced the patient's life to a very high extent). As 
expected, scores varied by NYHA class; the higher the 
NYHA class, the lower the reported HRQOL scores were (P
< .001). Patients above 75 years of age reported lower 
HRQOL as compared to patients younger than 75 (P = 
.02).
C haracteristics o f p rim ary care physicians
About 63% of the physician groups were (small) group 
practices. The mean age of the GPs across groups was 49.2 
years and mean number of years of experience since qual­
ification as a GP was 18.6.
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Table 2 presents the various physician groups as they 
structured their care for CHF patients. The mean sum 
score for the structured care characteristics was 8.3 (SD 
2.7). Few physician groups (10%) had special hours for 
heart disease patients, while around 19% held regular 
clinical meetings on CHF. Practice nurses and assistants 
were involved in  care for cardiovascular risk patients to a 
high extent; in 81% they were involved in systematically 
determining risk profiles; in 98% they did regular check­
ups of known patients with CHF, and in 56% they were 
involved in  case-finding. Finally, in  94% of physician 
groups they provided patients with oral or written infor­
mation. A 75% of the physician groups had written agree­
ments on when assistants and nurses should ask for 
feedback from their GP. A 10% of the groups used stand­
ardized forms for referral to specialized care.
Associations betw een structured  care characteristics and  
H R Q O L
No associations were found between the factors presented 
in  Table 2 and HRQOL. Bivariate analyses showed that in 
practices in  which someone was responsible for self-man­
agement in  patients with CHF, patients reported better 
quality of life (P = -9.91, P = .03). Also, in practices in 
which materials were provided to practice members 
regarding the needs of CHF patients, patients reported 
better HRQOL (P = -9.71, P = .03). However, both associ­
ations were not statistically significant when we repeated 
the analysis adjusting for patient age, sex and NYHA class 
(P = -3.6, P = .27, and P = -3.8, P = .21 respectively).
Associations betw een clin ical trea tm ent and H R Q O L
Optimal lifestyle advice was no t related to HRQOL, 
whereas optimal pharmacological treatment did relate to 
HRQOL. Patients who received optimal pharmacological 
treatment reported better HRQOL (P = -11.5, P < .0001). 
Adding the control variables did not change this relation.
Associations betw een structured  care characteristics and  
optim al treatm ent
No associations were found between the organizational 
factors and optimal pharmacological treatment. In bivari- 
ate analyses, it appeared that more lifestyle advice was 
given in  practices with an appointm ent system allowing 
contact with more than one professional during the 
encounter (P = 1.0, P = .04). Patients scored one point 
higher on the sum score for lifestyle advice (scale from 0 
to 8) compared with patients in practices not allowing for 
appointments with several care givers within one visit. 
Adding our control variables did not change this relation­
ship.
Discussion
Contrary to the expectation, HRQOL and treatment in 
chronic heart failure patients were not consistently associ­
ated with aspects of structured care characteristics of pri­
mary care practices. Our study involved a representative 
sample of general practices in the Netherlands. At the time 
of the study, no specific arrangements with insurers 
existed that may have influenced treatment.
Earlier studies that focused on the relationship between 
'structured care principles' and quality of (primary) care 
for various other conditions showed mixed results. One 
study that examined the chronic care model in preventing 
health risk behaviours in primary care found some associ­
ations e.g. between point-of-care reminders, clinical staff 
meetings and recommended services [20]. Also, a study in 
primary diabetes care found that planned care -  the 
implementation of practice guidelines, support for self­
management and clinical information systems -  was asso­
ciated with improved performance and most metabolic 
outcomes in patients on 2-year follow-up [28]. In addi­
tion, a study on the relation between 8 measures of pri­
mary health care orientation and the implementation of 
11 elements of chronic care management in  957 US phy­
sician organizations found that 6 of their 8 measures, 
including health education activity, were positively asso­
ciated with adoption of chronic care elements [29]. How­
ever, a study that tested whether improvements in care 
quality were correlated with changes in the chronic care 
model in 17 primary care clinics concluded that despite 
implementation of the chronic care model and improve­
ments in quality measures for three chronic conditions, 
there were very few significant relations between these 
changes [30]. Yet, their diabetes control measures were 
significantly associated with both clinical information 
systems and decision support. In addition, a cross-sec­
tional study on the association between quality of care 
and intensity of three disease management strategies (pro­
vider feedback, reminders, and structured care) found that 
more intense disease management strategies predicted 
higher scores on many process of care measures, but only 
one intermediate outcome and one medication manage­
m ent outcome [15].
So, although no t conclusive, the studies show some asso­
ciations between structured care and improved manage­
m ent of conditions, whereas our study mostly failed to 
show associations between structured care principles and 
clinical management. Possibly, this may be explained by 
variation in outcome measures. The am ount of variation 
in our outcome measures that could maximally be attrib­
uted to cluster level factors -  as measured by the intra­
cluster correlation (ICC) -  was for all three study out­
comes smaller than 10% (ranging from 1.5 to 8.2%). The 
variation in outcomes at practice level may have been 
higher in other studies. Also, both the observational stud­
ies had somewhat larger sample sizes than our study [211, 
306]. However, a post hoc sample size calculation for
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multiple regression analysis revealed that our sample size 
gave us 80% power to detect a R2 of 0.049 (for both 
HRQOL and lifestyle advice), assuming a type one error 
rate of 5% and a maximum of 4 factors in the model. This 
is comparable with a effect size for multiple regression f2 
of 0.051, which is a small effect according to Cohen 
[31,32].
Systematic reviews [19,21,33] on the effectiveness of com­
prehensive disease management programs (though 
mainly based on secondary care studies) in  improving 
clinical outcomes in HF, indicated that chronic care ele­
ments may improve both HF management as well as 
QOL. For instance, whereas we failed to find associations 
between structured care elements and improved pharma­
cological management, two of the 3 trials McAlister et al. 
included in  their review that assessed the medications of 
proven efficacy, demonstrated greater use of these thera­
pies in  the intervention studies. However, these improve­
ments on prescribing do not necessarily seem to be 
translated into improvements of QOL. Studies investigat­
ing the relation between pharmacological management 
and QOL mostly did not find an association [34,35]. The 
fact that we did find a significant relationship between 
optimal pharmacological treatment and HRQOL may be 
explained by our measure of optimal pharmacological 
treatment. This measure indicates whether the patients 
received all the indicated drugs, according to guideline 
recommendations. However, since patients in  lower 
NYHA classes need to receive fewer drugs than patients in 
higher NYHA classes, it is 'easier' to attain the score 'opti­
mal' for the patients in  lower classes, who in  general indi­
cate better QOL.
In addition, research suggested that one of the key ele­
ments to success in  disease management programs seems 
to be an emphasis on patient education and self-manage­
m ent [19,21]. These elements help to give patients a sense 
of control over their condition and their ability to prevent 
deterioration, and therefore may strongly influence QOL 
[36]. Several trials showed better adherence to self-man­
agement strategies and improved QOL when patients 
received appropriate education [21]. However, a recent 
study found that participation in  a quality improvement 
collaborative for heart failure was associated with better 
communication, knowledge, and lower health care use, 
but not with better QOL [37]. In bivariate analyses we 
found that patients in  practices in  which a) someone was 
responsible for self-management or b) in  which materials 
were provided to practice members regarding the needs of 
HF patients, patients reported better HRQOL. However, 
both associations were rather limited in  terms of clinical 
relevance and not statistically significant when we 
repeated the analysis adjusting for patient age, sex and 
NYHA class. Since NYHA class is consistently and closely
associated to QOL [4], this presumably points to a selec­
tion effect; it is likely that a certain patient population 
(e.g. a higher number of patients in higher NYHA classes) 
is selected in certain practices (e.g. the ones who have a 
practice member who is responsible for self manage­
ment). There is -  however -  a wide variety of programs 
and interventions that can be labelled 'disease manage­
ment' [22], and therefore it is not always clear what partic­
ular element in such a 'comprehensive program' results in 
successful outcomes, which complicates the comparison 
of several studies with our results.
Some possible limitations of our study should be noted. 
Measuring lifestyle advice, we used self-reported data, as 
preventive and counselling activities have been found to 
be under recorded in EMRs [38]. However, we cannot rule 
out recall bias [36,39], which may have underestimated 
our measures. In addition, we did not measure whether 
the patient received advice from other caregivers than the 
GP, such as the cardiologist, which may have diluted a 
possible relationship between lifestyle advice received 
from the GP and patient HRQOL. Also, our measure of 
optimal pharmacological treatment did no t take into 
account possible reasons to deviate from the suggestions 
in  the guidelines such as contra indications and intoler­
ance for drugs, multiple morbidities, or, simply, lack of 
robust evidence in  case of chronic heart failure with pre­
served systolic function [40,41]. Future studies should 
preferably measure these factors -  which may have caused 
underestimation of rates in  our study [42,43]. Finally, we 
like to note that we cannot conclude that we showed 
causal linkages, as we used a cross-sectional design.
Conclusion
This study is one of very few studies that explore the 
importance of structured care factors that may be related 
to HRQOL and high quality care in  heart failure in  a rep­
resentative sample of primary care practices. The presence 
of structured care elements varied widely. However, only 
few associations were found between the structured care 
characteristics and optimal management and HRQOL. 
Better insight into the possible relevance of these factors is 
of importance to guide the design of future practice m od­
els in  primary care that will contribute to high quality 
heart failure management, and -  ultimately -  higher 
HRQOL in patients. Future studies may benefit from more 
robust study designs, and combining quantitative and 
qualitative research methods [44] to disentangle what ele­
ments of disease management are effective and to gain 
more insights into possibly mediating or moderating fac­
tors. Also, more information on how to measure struc­
tured chronic care is needed [30], especially in primary 
care.
Page 6 of 8
(page number not for citation purposes)
BMC Health Services Research 2009, 9:104 http://www.biomedeentral.eom/1472-6963/9/104
Com peting interests
The authors declare that they have no competing interests. 
Authors' contributions
MB, TW, RG, HS, RA, LN and MW designed the study. MB 
performed the data collection and data analyses, and all 
other authors contributed to interpreting the data. RA per­
formed the multi-level logistic regression analyses. MB 
wrote the first draft, which was critically revised by all oth­
ers. All authors have read and approved the final m anu­
script.
Acknowledgem ents
W e thank all participating health care personnel and patients.
Funding source: ZonMw (the Netherlands organisation for health research 
and development), grant number 945-14-012.
References
1. Mosterd A, Hoes AW : C linical ep idem io logy o f h e art failure. 
Heart 2007, 93:1137-1 146.
2. Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, Vandermaas PJ: Esti­
m ating C lin ical M o rb id ity  D ue to  Ischem ic-H eart-D isease  
and C on ges tive -H eart-Fa ilu re  -  th e  Fu tu re  Rise o f H e a rt-  
Failure. American Journal o f Public Health 1994, 84:20-28.
3. W estert GP, Lagoe RJ, Keskimaki I, Leyland A, Murphy M: A n in te r­
national study o f hospital readmissions and re la ted  u tiliza­
tion in Europe and th e  U S A . Health Policy 2002, 61:269-278.
4. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog 
W , Haass M: H ea lth  re la ted  quality  o f life in patients w ith  con­
gestive h eart failure: com parison w ith  o th e r  chronic diseases 
and re la tion  to  functional variables. Heart 2002, 87:235-241.
5. Hunt SA, Abraham W T , Chin MH, Feldman AM, Francis GS, Ganiats 
TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko 
PS, Silver MA, Stevenson LW, Yancy CW : A C C /A H A  2005 G u ide­
line U pd ate  fo r th e  Diagnosis and M anag em ent o f Chronic  
H e a rt Failure in th e  A d u lt. Circulation 2005, 112:EI54-E235.
6. Rutten FH, Walma E, Kruizinga G, Bakx H, Van Lieshout J: N H G -  
S tandaard H artfa len , eerste  herziening. Huisarts en Wetenschap 
2005, 48:64-76.
7. Swedberg K, Cleland G, Dargie H, Follath F, Komajda M, Tavazzi L, 
Smiseth O, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, 
Levy S, Linde C, Lopez-Sendon J, Nijminen M, Pierard L, Remme W , 
Taske Force for the Diagnosis and Treatment of Chronic Heart Fail­
ure of the European Society of Cardiology: Guidelines fo r th e  diag­
nosis and tre a tm e n t o f chronic h e art failure: executive  
su m m ary (update  2005). European Heart Journal 2005, 
26:1 115-1140.
8. Cleland JGF, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, 
Freemantle N, Gavazzi A, van Gilst W H , Hobbs FDR, Korewicki J, 
Madeira HC, Preda I, Swedberg K, Widimsky J: M anag em ent o f 
h eart fa ilure in p rim ary  care (th e  IM P R O V E M E N T  o f H e a rt  
Failure P ro gram m e): an in ternational survey. Lancet 2002, 
360:1631-1639.
9. Rutten FH, Grobbee DE, Hoes AW : D ifferences betw een general 
practitioners and cardiologists in diagnosis and m anagem ent 
o f h e art failure: a survey in every-day practice. European Jour­
nal o f Heart Failure 2003, 5:337-344.
10. Ferlie EB, Shortell SM: Im proving th e  quality  o f health care in 
the U n ited  K ingdom  and th e  U n ited  States: a fra m e w o rk  fo r  
change. Milbank Quarterly 2001, 79:281-315.
11. Solberg LI: G uideline im p lem en tation : w h a t th e  lite ra tu re  
doesn't te ll us. Joint Commission Journal o f Quality Improvement 2000, 
26:525-537.
12. Moss F, Garside P, Dawson S: O rganisational change: the key to  
quality  im p ro vem en t. Quality in Health Care 1998, 7:SI-S2.
13. Bodenheimer T, Wagner EH, Grumbach K: Im proving prim ary  
care fo r patients w ith  chronic illness. Journal o f the American 
Medical Association 2002, 288:1775-1779.
14. Wagner EH, Austin BT, VonKorff M: O rgan izing  care fo r patients  
w ith  chronic illness. Milbank Quarterly 1996, 74:51 1-544.
15. Mangione CM, Gerzoff RB, Williamson DF, Steers W N , Kerr EA, 
Brown AF, Waitzfelder BE, Marrero DG, Dudley RA, Kim C, Herman 
W , Thompson TJ, Safford MM, Selby JV: T h e  association betw een  
quality  o f care and th e  intensity o f diabetes disease m anage­
m e n t program s. Annals o f Internal Medicine 2006, 145:107-116.
16. Olivarius ND, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen 
PA: Random ised contro lled  tr ia l o f s tructured  personal care  
o f type 2 diabetes m ellitus. British Medical Journal 2001, 
323:970-975.
17. Bodenheimer T, Lorig K, Holman H, Grumbach K: P atien t self­
m anagem en t o f chronic disease in p rim ary  care. Journal o f the 
American Medical Association 2002, 288:2469-2475.
18. Phillips CO, W right SM, Kern DE, Singa RM, Shepperd S, Rubin HR: 
C om prehensive discharge planning w ith  postdischarge sup­
p o rt fo r o lder patients w ith  congestive h e art fa ilure -  A  
m eta-analysis. Journal o f the American Medical Association 2004, 
291:1358-1367.
19. McAlister FA, Lawson FME, Teo KK, Armstrong PW: A  system atic  
rev iew  o f random ized tria ls  o f disease m anagem en t pro­
gram s in h e art fa ilure. American Journal o f Medicine 2001, 
1 10:378-384.
20. Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF: 
Rethinking prevention in p rim ary  care: A pplying th e  C hronic  
C a re  M odel to  address health risk behaviors. Milbank Quarterly
2007, 85:69-91.
21. Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F: T h e  
effectiveness o f disease m anagem en t program m es in reduc­
ing hospital re-adm ission in o ld er patients w ith  h eart failure: 
a system atic rev iew  and m eta-analysis o f published reports. 
European Heart Journal 2004, 25:1570-1595.
22. Mattke S, Seid M, Ma S: Evidence fo r th e  effect o f disease m an­
agem ent: is $1 billion a year a  good investment? American Jour­
nal o f Managed Care 2007, 13:670-676.
23. Wijbenga J, Duivenvoorden H, Balk AHMM, Simoons M, Erdman 
RAM: Q u a lity  o f Life in chronic h e art failure. V alidation  o f the  
D utch  version o f th e  M innesota Living w ith  H e a r t  Failure  
Q uestionnaire. Cardiologie 1998:627-632.
24. Bennett S, Oldridge N, Eckert G, Embree J, Browning S, Hou N, Deer 
M, Murray M: D iscrim inant properties o f co m m on ly  used qual­
ity  o f life m easures in h e art failure. Quality o f Life Research 2002, 
11:349-359.
25. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, Van Veld- 
huisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C: A d h e r­
ence to  guidelines is a  p red ic to r o f ou tco m e in chronic h eart 
failure: th e  M A H L E R  survey. European Heart Journal 2005, 
26:1653-1659.
26. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: 
Im proving chronic illness care: Translating evidence into  
action. Health Affairs 2001, 20:64-78.
27. Bonomi AE, Wagner EH, Glasgow RE, VonKorff M: Assessm ent o f  
C hron ic Illness C are  (A C IC ): A  practical to o l to  m easure  
quality  im provem ent. Health Services Research 2002, 37:791-820.
28. Montori vM, Dinneen SF, Gorman CA, Zimmerman BR, Rizza RA, 
Bjornsen SS, Green EM, Bryant SC, Smith SA: T h e  im pac t o f 
planned care and a diabetes electron ic m anagem en t system  
on com m unity-based diabetes care: th e  M ayo H ea lth  Sys­
te m  D iabetes Translation Pro ject. Diabetes Care 2002, 
25:1952-1957.
29. Schmittdiel JA, Shortell SM, Rundall TG , Bodenheimer T, Selby JV:
Effect o f p rim ary  health care o rien ta tio n  on chronic care  
m anagem en t. Annals o f Family Medicine 2006, 4: I 17-123.
30. Solberg LI, Crain AL, Sperl-Hillen JM, Hroscikoski MC, Engebretson 
KI, O'Connor PJ: C are  quality  and im p lem en ta tio n  o f the  
chronic care m odel: A  qu an tita tive  study. Annals o f Family Med­
icine 2006, 4 :3 10-316.
3 I . Cohen J, Cohen P, W est SG, Aiken LS: Applied Multiple Regression/Cor­
relation Analysis for the Behavioral Sciences Hillsdale, Mahwah, NJ: Law­
rence Earlbaum Associates; 2003.
32. Cohen J: Statistical Power Analysis for the Behavioral Sciences Hillsdale, 
NJ: Lawrence Earlbaum Associates; I988.
33. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S: Effective­
ness o f com prehensive disease m anagem en t program m es in 
im proving clinical outcom es in h eart fa ilure patients. A  
m eta-analysis. European Journal o f Heart Failure 2005, 7: I I3 3 - II4 4 .
Page 7 of 8
(page number not for citation purposes)
BMC Health Services Research 2009, 9:104 http://www.biomedeentral.eom/1472-6963/9/104
34. Dobre D, van Jaarsveld CHM, Ranchor AV, Arnold R, de Jongste MJL, 
Haaijer-Ruskamp FM: Evidence-based tre a tm e n t and quality  o f 
life in h e art failure. Journal o f Evaluation in Clinical Practice 2006, 
12:334-340.
35. Dobre D, van Jaarsveld CH, DeJongste MJ, Haaijer Ruskamp FM, Ran­
chor AV: T h e  effect o f be ta-b locker th erapy on quality  o f life 
in h e art fa ilure patients: a  system atic rev iew  and m eta -ana l­
ysis. Pharmacoepidemiological Drug Safety 2007, 16:152-159.
36. Lainscak M, Cleland JG, Lenzen MJ, Keber I, Goode K, Follath F, 
Komajda M, Swedberg K: N onpharm acologic m easures and 
drug com pliance in patients w ith  h eart failure: d a ta  fro m  the  
E u ro H e a rt Failure Survey. American Journal o f Cardiology 2007, 
99:3 I D-37D.
37. Baker D W , Asch SM, Keesey JW, Brown JA, Chan KS, Joyce G, 
Keeler EB: D ifferences in education, knowledge, self-m anage­
m en t activities, and health outcom es fo r patients w ith  heart 
fa ilure cared fo r under th e  chronic disease m odel: the  
im proving chronic illness care evaluation. Journal o f Cardiac Fail­
ure 2005, 11:405-413.
38. Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P: H o w  w ell 
does ch art d a ta  abstraction m easure quality? A  prospective  
com parison o f standardized patients w ith  th e  m edical 
record . The American Journal o f Medicine 2000, 108:642-649.
39. Lainscak M, Cleland JG, Lenzen MJ, Nabb S, Keber I, Follath F, Koma- 
jda M, Swedberg K: Recall o f lifestyle advice in patients recently  
hospitalised w ith  h e art failure: a  E u ro H e a rt Failure Survey  
analysis. European Journal o f Heart Failure 2007, 9 :1095-II03.
40. Boyd CM, Darer J, Boult C, Fried LP, Boult L, W u AW : Clinical 
practice guidelines and quality  o f care fo r o lder patients w ith  
m ultip le  com orb id  diseases -  Im plications fo r pay fo r per­
form ance. Journal o f the American Medical Association 2005, 
294:7I6-724.
41. van W eel C, Schellevis FG: C o m o rb id ity  and guidelines: conflict­
ing interests. Lancet 2006, 367:550-55I.
42. W alter LC, Davidowitz NP, Heineken PA, Covinsky KE: Pitfalls o f 
converting practice guidelines into quality  m easures -  Les­
sons learned fro m  a V A  perform ance m easure. JAMA 2004, 
291:2466-2470.
43. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SL, Bermann M, 
Hayward RA: Building a b e tte r  quality  m easure: A re  some 
patients w ith  "poor q uality” actually getting good care? Med­
ical Care 2003, 41: I I 73- I  I82.
44. Hearld L, Alexander J, Fraser I, Jiang H: H o w  do hospital organiza­
tional s tru ctu re  and processes affect quality  o f care? A  c r iti­
cal rev iew  o f research m ethods. Medical Care Research Review 
OnlineFirst 2007.
Pre-publication history
The pre-publication history for this paper can be accessed 
here:
http://www.biomedcentral.com/1472-6963/9/104/pre
pub
Publish with B io Med Central and every 
scientist can read your work free of charge
"BioMed Central w ill be the most significant development fo r  
disseminating the results o f  biomedical research in ou r life tim e ."
Sir Paul Nurse, Cancer Research UK
Your research papers w ill be:
• available free of charge to the entire biomedical community
• peer reviewed and published immediately upon acceptance
• cited in PubMed and archived on PubMed Central
• yours — you keep the copyright
Submit your manuscript here: ^  J  B i o M © d c 6 n t r 3 l
http://www.biomedcentral.com/info/publishing_adv.asp S
Page 8 of 8
(page number not for citation purposes)
